Floatz logo

Therapeutic Asset Ratings

409 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Telaglenastat
Ovarian Cancer
University of Alabama at BirminghamP1C (36)
TEONANACATL
Ovarian Cancer
University of Colorado, DenverP1C (36)
Torl-1-23
Ovarian Cancer
TORL Biotherapeutics, LLCP1C (36)
Trk-950
Ovarian Cancer
Toray Industries, IncP1C (36)
Tsc-200-A0201
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-201-B0702
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-202-A0201
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-203-A0201
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-204-A0101
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-204-A0201
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Tsc-204-C0702
Ovarian Cancer
TScan Therapeutics, Inc.P1C (36)
Xmab541
Ovarian Cancer
Xencor, Inc.P1C (36)
Xmab808
Ovarian Cancer
Xencor, Inc.P1C (36)
Zi-Ma4-1
Ovarian Cancer
Zelluna Immunotherapy ASP1C (36)
Bemarituzumab
Ovarian Cancer
Centre Leon BerardP1/2C (36)
Maplirpacept
Ovarian Cancer
PfizerP1/2C (35)
kt032
Ovarian Cancer
Weijia Fang, MDEarly P1C (33)
Montelukast
Ovarian Cancer
University of South FloridaEarly P1C (33)
nk521 cell
Ovarian Cancer
Base Therapeutics (Shanghai) Co., Ltd.Early P1C (33)
R130
Ovarian Cancer
Shanghai Yunying Medical TechnologyEarly P1C (33)
Nanrilkefusp Alfa
Ovarian Cancer
SOTIO Biotech AGP2D (30)
Luveltamab Tazevibulin
Ovarian Cancer
Sutro Biopharma, Inc.P2/3D (30)
Sasanlimab
Ovarian Cancer
PfizerP1D (27)
Amitriptyline
Ovarian Cancer
Zhejiang Cancer HospitalN/AD (26)
Huaier Granule
Ovarian Cancer
Ruijin HospitalN/AD (26)
Showing 376 to 400 of 409 assets
PreviousPage 16 of 17Next